View Author
screening cancer women study colorectal model colonoscopy colorectal cancer result smear group health netherland incidence number table effect adenomas strategy treatment population vaccination analysis cost-effectiveness stage mortality trial adenoma individual interval colorectal cancer screening sensitivity detection level cohort difference death dutch ct colonography value follow-up colonography van ballegooijen m lesion cancer screening policy history patient surveillance testing round disease hpv vaccination program diagnosis estimate programme trend cytology participant sample ratio wamen life-year assumption polyps blood period increase occult duration sigmoidoscopy country family history decision vaccine screening program colon intervention referral
10 Most Recent Publications
|
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
(Article)
Goede, S.L. Roon, A.H.C. van Reijerink, J.C.I.Y. Vuuren, A.J. van Lansdorp-Vogelaar, I. Habbema, J.D.F. Kuipers, E.J. Leerdam, M.E. van Ballegooijen, M. van |
2013-05-01
|
|
What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
(Article)
Dam, L. van Korfage, I.J. Kuipers, E.J. Hol, L. Roon, A.H.C. van Reijerink, J.C.I.Y. Ballegooijen, M. van Leerdam, M.E. van |
2013-04-08
|
|
Parental Decisional Strategies Regarding HPV Vaccination Before Media Debates: A Focus Group Study
(Article)
Hofman, R. Empelen, P. van Vogel, I. Raat, H. Ballegooijen, M. van Korfage, I.J. |
2013-04-08
|
|
Multicohort models in cost-effectiveness analysis: Why aggregating estimates over multiple cohorts can hide useful information
(Article)
O'Mahony, J.F. Rosmalen, J.M. van Zauber, A.G. Ballegooijen, M. van |
2013-04-01
|
|
Genetic data provide evidence for wind-mediated transmission of highly pathogenic avian influenza
(Article)
Ypma, P.F. Jonges, M. Bataille, A. Stegeman, A. Koch, G. Boven, M. van Koopmans, M.G.P. Ballegooijen, M. van Wallinga, J. |
2013-03-01
|
|
Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
(Article)
Kok, I.M.C.M. de Rosmalen, J.M. van Dillner, J. Arbyn, M. Sasieni, P. Ballegooijen, M. van |
2012-03-01
|
|
Are fecal immunochemical test characteristics influenced by sample return time a population-based colorectal cancer screening trial
(Article)
Roon, A.H.C. van Hol, L. Kuipers, E.J. Leerdam, M.E. van Vuuren, A.J. van Francke, J. Ouwendijk, M. Heijens, A. Nagtzaam, N.M. Reijerink, J.C.I.Y. Togt, A.C.M. van der Ballegooijen, M. van |
2012-01-01
|
|
Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: A randomised controlled trial
(Article)
Stoop, E. Haan, M.C. de Fockens, P. Stoker, J. Kuipers, E.J. Dekker, E. Wijkerslooth, T.R. de Bossuyt, P.M.M. Ballegooijen, M. van Nio, C.Y. Vijver, M.J. van de Biermann, K. Thomeer, M. Leerdam, M.E. van |
2012-01-01
|
|
Fecal occult blood testing when colonoscopy capacity is limited
(Article)
Wilschut, J.A. Habbema, J.D.F. Leerdam, M.E. van Hol, L. Lansdorp-Vogelaar, I. Kuipers, E.J. Ballegooijen, M. van |
2011-12-07
|
|
Practical implications of differential discounting of costs and health effects in cost-effectiveness analysis
(Article)
O'Mahony, J.F. Kok, I.M.C.M. de Rosmalen, J.M. van Habbema, J.D.F. Brouwer, W.B.F. Ballegooijen, M. van |
2011-12-01
|
